Document is current
Any future updates will be listed below
-
Authors
Gault, Judith M.
Cascella, Nicola
Moukaddam, Nidal
Lehto, Stephanie
Hosokawa, Patrick
Appelbaum, Paul S.
Sawa, Akira
Lippman-Bell, Jocelyn
Anderson, William S.
Goodman, Wayne
Sheth, Sameer A.
Kramer, Daniel
Thompson, John A.
Saks, Elyn R.
Davis, Rachel A.
-
Funding
Funding for this research was provided by:
National Institutes of Health (MH121362, MH121362, MH121362, MH121362, MH121362, MH121362, MH121362, MH121362, MH121362, MH121362, MH121362)
- License Information
-
More Information
Article History
Received: 7 January 2025
Accepted: 19 June 2025
First Online: 19 August 2025
Declarations
:
: This study was IRB approved (COMIRB# 18-2885). Research participants provided consent for study. The IRB approved the waiving of audience participants and; consent to participate to respond to polls during presentations. Polling during presentations was anonymous. Consent to publish was not required.
: Not applicable.
: SAS is a consultant for Boston Scientific, Zimmer Biomet, Neuropace, and Koh Young and is co-founder of Motif Neurotech. WKG receives royalty payments from Nview, LLC and OCDscales, LLC. RAD provides paid Ad Hoc consultation for Medtronic. JMG owns Pfizer stock. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
